My ePortfolio Register   

Targeting the cancer genome

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 13.04.12
Views: 5086
Rating:

Dr Bill Sellers - Novartis Institutes for Biomedical Research, Cambridge, Massachusetts

Dr Bill Sellers talks about his session at the AACR 2012 Annual Meeting on the five key issues on the genetic basis of cancer drug development.

 

Dr Sellers mentions previously successful drugs, such as gleevec, and how there needs to be a greater understanding of the cancer genome, which will lead to more therapies for diseases once thought to be unaffected by this type of treatment.

Related videos

follow us



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence